Your browser doesn't support javascript.
loading
The incidence of skin lesions in contrast media-induced chemical hypersensitivity.
Iordache, Andrei Mihai; Docea, Anca Oana; Buga, Ana Maria; Mitrut, Radu; Albulescu, Dana; Zlatian, Ovidiu; Ianosi, Simona; Ianosi, Gabriel; Neagoe, Daniela; Sifaki, Maria; Rogoveanu, Otilia Constantina; Branisteanu, Daciana Elena; Calina, Daniela.
Afiliação
  • Iordache AM; Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Docea AO; Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Buga AM; Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Mitrut R; Department of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Albulescu D; Department of Radiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Zlatian O; Department of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Ianosi S; Department of Dermatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Ianosi G; Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Neagoe D; Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Sifaki M; Laboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, Crete, Greece.
  • Rogoveanu OC; Department of Physical Medicine and Rehabilitation, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Branisteanu DE; Department of Dermatology, University of Medicine and Pharmacy 'Gr. T. Popa', 700115 Iasi, Romania.
  • Calina D; Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Exp Ther Med ; 17(2): 1113-1124, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30679982
ABSTRACT
Contrast agents are used in radiology to increase the sensibility and specificity of radiological techniques. Some of these compounds have side effects that include organ toxicity (with kidney being the most affected organ) and hypersensitivity reactions. We performed multiple PubMed searches from January, 2008 to January, 2018 for studies regarding adverse reactions to compounds used as contrast agents in imagistic techniques. The initial research identified 929 records written in English. After further excluding 223 non-human studies, 292 articles that had irrelevant designs as reviews, meta-analysis, commentaries, editorials and case reports, 414 studies were selected for retrieval. After reading the abstracts, we excluded 363 studies as they had little relevance to the study. In total, 51 full-articles were assessed for eligible studies to be included. Finally, 20 articles were included in the analysis. In our systematic literature search the incidence of overall skin immediate reactions to iodinated contrast media (ICM) had an incidence between 1.15 and 0.12%, depending on the cohort analyzed in the studies. The percentage of cutaneous manifestations in the cohort that experienced immediate hypersensitivity reactions was between 33.33 and 87.7%. The most frequent skin manifestations were urticaria, rashes, pruritus and limited facial edema. Non-iodinated contrast agents have a safer profile compared with ICM, the incidence of immediate adverse reactions being very low in gadolinium-based contrast agents and other agents used for contrast-enhanced ultrasound. The incidence of delayed reactions was between 10.1 and 0.03%. In the studies analyzed by us the main adverse reactions due to delayed hypersensitivity phenomena were cutaneous manifestations that were present between 70.27 and 100% of the cases. Regarding the risk factors for developing immediate adverse reactions, being female was a predisposing factor accompanied by history of allergy and history of reactions to contrast media. An accurate anamnesis of the patients and a correctly conducted pretreatment can limit the incidence and the severity of the adverse reactions and also can avoid the life occurrence of life-threatening reactions.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Exp Ther Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Romênia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Exp Ther Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Romênia